The global Brain Tumour Therapeutics market is expected to reach USD 2.90 Billion by 2030, at a CAGR of 11.18% during the forecast period 2022 to 2030.When brain cells proliferate uncontrollably and form tumours, brain cancer is the result. With this situation, cancerous cells grow in the brain tissue. A tumour is created when cancer cells multiply and cause disruptions in the brain's ability to control sensation, muscle movement, memory, and other basic functions.